APA

Brown G. D., Luthra S. K., Brock C. S., Stevens M. F. G., Price P. M. & Brady F. (20030107). Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies. : Journal of medicinal chemistry.

Chicago

Brown Gavin D, Luthra Sajinder K, Brock Cathryn S, Stevens Malcolm F G, Price Patricia M and Brady Frank. 20030107. Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies. : Journal of medicinal chemistry.

Harvard

Brown G. D., Luthra S. K., Brock C. S., Stevens M. F. G., Price P. M. and Brady F. (20030107). Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies. : Journal of medicinal chemistry.

MLA

Brown Gavin D, Luthra Sajinder K, Brock Cathryn S, Stevens Malcolm F G, Price Patricia M and Brady Frank. Antitumor imidazotetrazines. 40. Radiosyntheses of [4-11C-carbonyl]- and [3-N-11C-methyl]-8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (temozolomide) for positron emission tomography (PET) studies. : Journal of medicinal chemistry. 20030107.